Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

More articles by this author

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD

Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD

Bleeding Risk Estimation and the New (BARC) Definition of Bleeding Events Dr. Franz Weidinger

Bleeding Risk Estimation and the New (BARC) Definition of Bleeding Events Dr. Franz Weidinger

Which Antiplatelet Therapy for Which Patient? Dr. Thomas Cuisset

Which Antiplatelet Therapy for Which Patient? Dr. Thomas Cuisset

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...